Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Group A
Reference Group
Start Date
February 1, 2025
Primary Completion Date
May 1, 2025
Completion Date
December 1, 2025
Last Updated
February 17, 2025
NCT07345130
NCT06969963
NCT06924190
NCT06758531
NCT06600282
NCT06579053
Lead Sponsor
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions